serw-MX  [xml]  
 


    
 DeCS Categories

D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.519 Molecular Mechanisms of Pharmacological Action .
D27.505.519.389 Enzyme Inhibitors .
D27.505.519.389.745 Protease Inhibitors .
D27.505.519.389.745.325 Cysteine Proteinase Inhibitors .
D27.505.519.389.745.325.500 Caspase Inhibitors .
D27.505.519.562 Membrane Transport Modulators .
D27.505.519.562.750 Sodium Channel Blockers .
D27.505.519.562.750.100 Acid Sensing Ion Channel Blockers .
D27.505.519.625 Neurotransmitter Agents .
D27.505.519.625.050 Adrenergic Agents .
D27.505.519.625.050.200 Adrenergic Antagonists .
D27.505.519.625.150 Dopamine Agents .
D27.505.519.625.150.175 Dopamine Antagonists .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.577 Neurotransmitter Agents .
D27.505.696.577.050 Adrenergic Agents .
D27.505.696.577.050.200 Adrenergic Antagonists .
D27.505.696.577.150 Dopamine Agents .
D27.505.696.577.150.175 Dopamine Antagonists .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Acid Sensing Ion Channel Blockers .
ASIC Blockers .
ASIC Channel Antagonists .
ASIC Channel Blockers .
ASIC Inhibitors .
Acid Sensing Ion Channel Inhibitors .
Antagonists, ASIC Channel .
Blockers, ASIC Channel .
Channel Antagonists, ASIC .
Channel Blockers, ASIC .
Proton Gated Sodium Channel Blockers .
Proton-Gated Sodium Channel Blockers .
A subclass of sodium channel blockers that are specific for ACID-SENSING SODIUM CHANNELS. .
1.00
074
 
Adrenergic Antagonists .
Adrenergic Antagonist .
Adrenergic Blockaders .
Adrenergic Blocker .
Adrenergic Blockers .
Adrenergic Receptor Antagonists .
Adrenergic Receptor Blockaders .
Adrenolytic Agents .
Adrenolytic Drugs .
Anti-Adrenergics .
Antiadrenergics .
Receptor Antagonists, Adrenergic .
Adrenergic Blocking Agents .
Agents, Adrenergic-Blocking .
Agents, Adrenolytic .
Agents, Antiadrenergic .
Antagonist, Adrenergic .
Antagonists, Adrenergic .
Antagonists, Adrenergic Receptor .
Anti Adrenergics .
Blockaders, Adrenergic .
Blockaders, Adrenergic Receptor .
Blocker, Adrenergic .
Blockers, Adrenergic .
Drugs, Adrenolytic .
Receptor Blockaders, Adrenergic .
Adrenergic-Blocking Agents .
Adrenolytics .
Antiadrenergic Agents .
Drugs that bind to but do not activate ADRENERGIC RECEPTORS. Adrenergic antagonists block the actions of the endogenous adrenergic transmitters EPINEPHRINE and NOREPINEPHRINE. .
0.57
20990
 
Caspase Inhibitors .
Capase Activation Inhibitors .
Caspase Activation Blockers .
Caspase Activation Inhibitors .
Caspase Blockers .
Activation Blockers, Caspase .
Activation Inhibitors, Capase .
Activation Inhibitors, Caspase .
Blockers, Caspase .
Blockers, Caspase Activation .
Inhibitors, Capase Activation .
Inhibitors, Caspase .
Inhibitors, Caspase Activation .
Endogenous and exogenous compounds and that either inhibit CASPASES or prevent their activation. .
0.54
25160
 
Dopamine Antagonists .
Antagonists, Dopamine .
Antagonists, Dopamine Receptor .
Antagonists, Dopaminergic .
Dopamine Blockers .
Blockers, Dopamine .
Receptor Antagonists, Dopamine .
Dopamine Receptor Antagonists .
Dopaminergic Antagonists .
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. .
0.52
4510087